venBio Select Advisor

Avoro Capital Advisors as of June 30, 2025

Portfolio Holdings for Avoro Capital Advisors

Avoro Capital Advisors holds 30 positions in its portfolio as reported in the June 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ascendis Pharma Sponsored ADR (ASND) 15.1 $860M 5.0M 172.60
United Therapeutics Corp Common (UTHR) 11.9 $681M 2.4M 287.35
Argenx Se Sponsored ADR (ARGX) 11.3 $648M 1.2M 551.22
Madrigal Pharmaceuticals Common (MDGL) 9.9 $568M 1.9M 302.64
Krystal Biotech Common (KRYS) 6.4 $366M 2.7M 137.46
Kymera Therapeutics Common (KYMR) 5.0 $286M 6.6M 43.64
Apellis Pharmaceuticals Common (APLS) 3.7 $212M 12M 17.31
Avidity Biosciences Common (RNA) 3.5 $200M 7.1M 28.40
Moonlake Immunotherapeutics Class A Ord (MLTX) 3.4 $196M 4.2M 47.20
Akero Therapeutics Common (AKRO) 3.3 $187M 3.5M 53.36
Soleno Therapeutics Common (SLNO) 3.0 $172M 2.1M 83.78
Xenon Pharmaceuticals Common (XENE) 3.0 $169M 5.4M 31.30
Arrowhead Pharmaceuticals Common (ARWR) 2.9 $168M 11M 15.80
Merus N V Common (MRUS) 2.9 $166M 3.2M 52.60
Vera Therapeutics Common (VERA) 2.6 $148M 6.3M 23.56
Amicus Therapeutics Common (FOLD) 1.8 $103M 18M 5.73
Alkermes Common (ALKS) 1.5 $83M 2.9M 28.61
Ocular Therapeutix Common (OCUL) 1.2 $69M 7.4M 9.28
89bio Common (ETNB) 1.2 $66M 6.8M 9.82
Centessa Pharmaceuticals Sponsored Adr (CNTA) 1.2 $66M 5.0M 13.14
Uniqure Nv Common (QURE) 0.9 $51M 3.6M 13.94
Taysha Gene Therapies Common (TSHA) 0.9 $50M 22M 2.31
Blueprint Medicines Corp Common (BPMC) 0.8 $48M 375k 128.18
Tourmaline Bio Common (TRML) 0.7 $41M 2.6M 15.99
Biocryst Pharmaceuticals Common (BCRX) 0.7 $40M 4.5M 8.96
Mannkind Corp Common (MNKD) 0.4 $22M 5.9M 3.74
Monte Rosa Therapeutics Common (GLUE) 0.3 $17M 3.7M 4.51
Septerna Common (SEPN) 0.2 $13M 1.2M 10.57
Ultragenyx Pharmaceutical Common (RARE) 0.2 $12M 330k 36.36
Whitehawk Therapeutics Common (WHWK) 0.1 $5.3M 2.8M 1.87